Lupin launches AI-powered cardiometabolic wellness platform

Lupin Digital Health has announced the launch of VITALYFE™, an artificial intelligence (AI)-powered cardiometabolic wellness platform designed to help India’s working professionals reclaim their heart health.

Built on the foundation of LYFE — India’s first CDSCO-approved Class C software medical device (SaMD) for critical cardiac conditions — VITALYFE™ extends hospital-grade cardiac expertise to preventive wellness for its users.

India’s corporate employees face a growing cardiometabolic crisis. Studies indicate that up to 80 percent show early signs of hypertension and dyslipidemia — silent accelerators of heart aging. Long work hours, chronic stress, sedentary routines, poor nutrition, and inadequate sleep are causing hearts to age faster than bodies. If unaddressed, this would leave millions at risk of cardiovascular disease during their most productive years.

Developed with industry-leading cardiometabolic expertise, VITALYFE™ uses artificial intelligence, behavioral science, and computer-vision technology to identify early risks and provide personalised, non-medical interventions that address the root causes of heart ageing.

“At Lupin Digital Health, we have seen how evidence-based digital therapeutics through LYFE have transformed cardiac recovery,” said Sidharth Srinivasan, Chief Executive Officer – Lupin Digital Health. “With VITALYFE, we are extending that scientific foundation to a much larger audience — helping professionals understand their heart age, make better lifestyle choices, and literally make their hearts younger. Our vision is to make cardiometabolic wellness both measurable and mainstream.”